DBSDF·006175203·US·Common Stock·Financial Services - Banks - Regional
DBSDF (BioCryst Pharmaceuticals Inc) is held by 1 institutional investors as of Q1 2026. Largest holders: Aristotle Capital Management, LLC ($127.7M), Pacer Advisors, Inc. ($15.6M).
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer